Search research articles
Contact Us
Filters
Showing results (1-10 of 17) with videos related to
Page
of 2
Sort By:
Seminars in Hematology
|
July 16, 2023
Blood has never been thicker: Cell-free DNA fragmentomics in the liquid biopsy toolbox of B-cell lymphomas
Leo Meriranta, Esa Pitkänen, Sirpa Leppä
Duodecim; Laaketieteellinen Aikakauskirja
|
December 15, 2017
Clinical significance of gene defects in B-cell lymphomas
Annika Pasanen, Leo Meriranta, Sirpa Leppä
Cancer Immunology Research
|
August 7, 2025
Spatial Analysis of the Tumor Microenvironment in Diffuse Large B-Cell Lymphoma Reveals Clinically Relevant Cell Interactions and Recurrent Cellular Neighborhoods
Matias Autio, Suvi-Katri Leivonen, Leo Meriranta, et al.
Blood Advances
|
August 12, 2020
Molecular background delineates outcome of double protein expressor diffuse large B-cell lymphoma
Leo Meriranta, Annika Pasanen, Amjad Alkodsi, et al.
Therapeutic Advances in Gastroenterology
|
February 18, 2025
Higher disease activity of inflammatory bowel disease predisposes to <i>Clostridioides difficile</i> infection
Krista Vitikainen, Merit Kase, Leo Meriranta, et al.
Therapeutic Advances in Gastroenterology
|
October 30, 2025
Gastrointestinal bacterial infections precede disease activation and treatment intensification in patients with inflammatory bowel disease
Merit Kase, Krista Johanna Vitikainen, Clas-Göran Af Björkesten, et al.
Leukemia
|
June 13, 2019
Distinct subtypes of diffuse large B-cell lymphoma defined by hypermutated genes
Amjad Alkodsi, Alejandra Cervera, Kaiyang Zhang, et al.
Leukemia
|
April 22, 2026
A targeted circulating tumor DNA landscape of copy number aberrations in large B-cell lymphomas
Maare Arffman, Leo Meriranta, Judit Jørgensen, et al.
Blood Cancer Discovery
|
April 17, 2024
Disruption of KLHL6 Fuels Oncogenic Antigen Receptor Signaling in B-Cell Lymphoma
Leo Meriranta, Selma Sorri, Kanutte Huse, et al.
Med (New York, N.Y.)
|
April 5, 2024
Inflammatory and subtype-dependent serum protein signatures predict survival beyond the ctDNA in aggressive B cell lymphomas
Maare Arffman, Leo Meriranta, Matias Autio, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 17) with videos related to
Sort By:
Page
of 2
Seminars in Hematology
|
July 16, 2023
Blood has never been thicker: Cell-free DNA fragmentomics in the liquid biopsy toolbox of B-cell lymphomas
Leo Meriranta, Esa Pitkänen, Sirpa Leppä
Duodecim; Laaketieteellinen Aikakauskirja
|
December 15, 2017
Clinical significance of gene defects in B-cell lymphomas
Annika Pasanen, Leo Meriranta, Sirpa Leppä
Cancer Immunology Research
|
August 7, 2025
Spatial Analysis of the Tumor Microenvironment in Diffuse Large B-Cell Lymphoma Reveals Clinically Relevant Cell Interactions and Recurrent Cellular Neighborhoods
Matias Autio, Suvi-Katri Leivonen, Leo Meriranta, et al.
Blood Advances
|
August 12, 2020
Molecular background delineates outcome of double protein expressor diffuse large B-cell lymphoma
Leo Meriranta, Annika Pasanen, Amjad Alkodsi, et al.
Therapeutic Advances in Gastroenterology
|
February 18, 2025
Higher disease activity of inflammatory bowel disease predisposes to <i>Clostridioides difficile</i> infection
Krista Vitikainen, Merit Kase, Leo Meriranta, et al.
Therapeutic Advances in Gastroenterology
|
October 30, 2025
Gastrointestinal bacterial infections precede disease activation and treatment intensification in patients with inflammatory bowel disease
Merit Kase, Krista Johanna Vitikainen, Clas-Göran Af Björkesten, et al.
Leukemia
|
June 13, 2019
Distinct subtypes of diffuse large B-cell lymphoma defined by hypermutated genes
Amjad Alkodsi, Alejandra Cervera, Kaiyang Zhang, et al.
Leukemia
|
April 22, 2026
A targeted circulating tumor DNA landscape of copy number aberrations in large B-cell lymphomas
Maare Arffman, Leo Meriranta, Judit Jørgensen, et al.
Blood Cancer Discovery
|
April 17, 2024
Disruption of KLHL6 Fuels Oncogenic Antigen Receptor Signaling in B-Cell Lymphoma
Leo Meriranta, Selma Sorri, Kanutte Huse, et al.
Med (New York, N.Y.)
|
April 5, 2024
Inflammatory and subtype-dependent serum protein signatures predict survival beyond the ctDNA in aggressive B cell lymphomas
Maare Arffman, Leo Meriranta, Matias Autio, et al.
Page
of 2